| A2M | Alpha-2-macroglobulin |
| AGT | Angiotensinogen |
| APOA1 | Apolipoprotein A1 |
| APOA4 | Apolipoprotein A4 |
| APOC3 | Apolipoprotein C3 |
| APOM | Apolipoprotein M |
| BMI | Body Mass Index |
| BS | Bariatric Surgery |
| CRP | C—reactive protein |
| CVD | Cardiovascular disease |
| EETs | Epoxyeicoasatrienoic acids |
| EPHX2 | Bifunctional epoxide hydrolase 2 |
| FE | Fold Enrichment |
| FN1 | Fibronectin |
| GO | Gene Ontology |
| HbA1c | glycosylated haemoglobin |
| HCC | Hepatocellular carcinoma |
| HOMA-B | Homeostatic model assessment of beta cell function |
| HOMA-IR | Homeostatic model assessment of insulin resistance |
| HP | Haptoglobulin |
| HSPA4 | Heat shock 70 kDa protein 4 |
| IGF-II | Insulin-like growth factor II |
| LC-MS | Liquid Chromatography Mass spectrometry |
| LRG1 | Leucine-rich alpha-2-glycoprotein |
| NAHS | Non-Alcoholic Hepatic Steatosis |
| PCA | Principal component analysis |
| PGLYRP2 | N-acetylmuramoyl-L-alanine amidase |
| PRG4 | Proteoglycan 4 |
| SERPINC1 | Antithrombin-III |
| SERPING1 | Plasma protease C1 inhibitor |
| SHBG | Sex Hormone Binding Globulin |
| SWATH-MS | Sequential window acquisition of all theoretical fragment ion spectra Mass Spectrometry |
| T2DM | Type 2 Diabetes Mellitus |
| TF | Serotransferrin |